Program Overview
| Monday, December 02, 2024 | ||
| 08:00 – 09:00 | Registration | |
| 09:00 – 17:00 | Global Surveillance Summit / FIDSSA Pre-ICID 2024 Educational Workshop | |
| Tuesday, December 03, 2024 | ||
| 08:00 – 09:00 | Registration | |
| 09:00 – 17:00 | ICID 2024 Workshops | |
| 17:30 – 18:30 | ICID 2024 Opening Ceremony | |
| 18:30 – 21:00 | ICID 2024 Welcome Reception | |
| Wednesday, December 04, 2024 | ||
| 08:00 – 19:30 | ICID 2024 | |
| Thursday, December 05, 2024 | ||
| 08:00 – 18:00 | ICID 2024 | |
| 19:00 – 21:00 | President’s Welcome Reception | |
| Friday, December 06, 2024 | ||
| 08:00 – 16:30 | ICID 2024 | |
| 16:30 – 16:45 | President's Closing Remarks | |
| * All times subject to change | ||
Mon, 02 Dec 2024
Tue, 03 Dec 2024
Wed, 04 Dec 2024
Thu, 05 Dec 2024
Fri 06 Dec 2024
Mon, 02 Dec 2024
| 09:00-12:00 | Surveillance Summit | FIDSSA Pre-ICID 2024 Educational Workshop (Full Day) |
| 12.00-13.00 | ||
| 14.00-17.00 |
Tue, 03 Dec 2024
| 08:00-09:00 | Registration | ||||
| 09:00-12:00 | Workshop: Epidemiologic Intelligence and Forecasting Approaches |
Workshop: AMR Stewardship – What the ID Professional Needs to Know! |
Workshop: Appropriate Use of the Latest Laboratory Technologies & New Trends in Clinical Quality Assurance |
Workshop: The Pharmacist’s Role in the Infectious Diseases Team |
|
| 12.00-13.00 | Lunch & Exhibition, Poster Presentations – Exhibition Hall 3 & 4, Ground Floor | ||||
| 14.00-17.00 | Workshop | Workshop | Workshop | Workshop | |
| 17:30-18:30 | Opening Ceremony | ||||
| 18:30-20:00 | Welcome Reception | ||||
Wed, 04 Dec 2024
| 07:30-08:00 | Industry Sponsored | Industry Sponsored | ||||||||
| 08:00-09:00 | Meet-the-Expert: Lab biosafety and biosecurity | Meet-the-Expert: Infections in immunocompromised | Meet-the-Expert: Surgical infections and antibiotic use | |||||||
| 09:00-10:30 | Plenary 1: Climate change and Infectious Diseases | |||||||||
| 10:30-11:00 | Coffee Break (Exhibition Hall 3 & 4, Ground Floor) | |||||||||
| 11:00-12:30 | Industry Sponsored | Scientific (S1): One Health session: Surveillance | Oral Abstract Presentations (O1) | Scientific (S3): AI and Infectious Diseases | Scientific (S3): AI and Infectious Diseases | Policy Session (P1): Policy Discussion – Health systems resilience | Scientific (S4): Mass drug administration | WG1: Guide to Infection Control Working Group | ||
| 12:30-14:00 | Lunch & Exhibition, Poster Presentations – Exhibition Hall 3 & 4, Ground Floor | Industry Sponsored | Industry Sponsored | Industry Sponsored | ||||||
| 14:00-15:30 | Industry Sponsored | Scientific (S5): Enteric Infections | Oral Abstract Presentations (O2) | Scientific (S6): Global Genomic ID Surveillance and Response | Scientific (S7): Rabies: Key Areas | Scientific (S8): Respiratory infections | Scientific (S9): Perspectives from ISID Emerging Leaders | |||
| 15:30-16:00 | Coffee Break (Exhibition Hall 3 & 4, Ground Floor) | |||||||||
| 16:00-17:00 | Plenary 2: Tuberculosis | |||||||||
| 17:15-18:45 | Industry Sponsored | |||||||||
Thu, 05 Dec 2024
| 07:30-08:00 | Industry Sponsored | Industry Sponsored | |||||
| 08:00-09:00 | Meet-the-Expert: Meet-the-Editors |
Meet-the-Expert: Urinary tract infections |
Meet-the-Expert: Career in Public Health/Global Health |
||||
| 09:00-10:30 | Oral Abstract Presentations (O3) | Industry Sponsored | Industry Sponsored | Industry Sponsored | |||
| 10:30-11:00 | Coffee Break (Exhibition Hall 3 & 4, Ground Floor) | ||||||
| 11:00-12:30 | Plenary 3: AMR |
||||||
| 12:30-14:00 | Lunch & Exhibition, Poster Presentations – Exhibition Hall 3 & 4, Ground Floor | Industry Sponsored | Industry Sponsored | Industry Sponsored | |||
| 14:00-15:30 | Scientific (S10): Clinical management of hard-to-treat infections |
Oral Abstract Presentations (O4) | Scientific (S11): Pediatric infectious diseases – Challenges and Opportunities |
Scientific (S12): HIV – Hot Topics |
Policy Session (p2): Policy Discussion – Pandemic Centers |
||
| 15:30-16:00 | Coffee Break (Exhibition Hall 3 & 4, Ground Floor) | ||||||
| 16:00-17:00 | Scientific (S13): Hospital-Acquired Infections – How Much Can We Prevent |
Scientific (S14): Hepatitis B and C – Global Opportunities |
Scientific (S15): Point of Care Testing |
Scientific (S16): AMR surveillance and diagnostic |
Oral Abstract Presentations (O5) | Scientific (S17): Neglected Infectious Diseases |
Oral Abstract Presentations (O6) |
| 17:00-18:30 | Plenary 4: Malaria |
||||||
Fri 06 Dec 2024
| 08:00-09:00 | Industry Sponsored | Industry Sponsored | ||||||||
| 08:00-09:00 | Meet-the-Expert: Meet the ProMED Moderators |
Meet-the-Expert: Neonatal infections |
Meet-the-Expert: The best of the joint HIV ID Meeting |
|||||||
| 09:00-10:30 | Oral Abstract Presentations (O7) | |||||||||
| 10:30-11:00 | Coffee Break (Exhibition Hall 3 & 4, Ground Floor) | |||||||||
| 11:00-12:30 | Plenary 5: Pandemic preparedness |
|||||||||
| 12:30-14:00 | Lunch & Exhibition, Poster Presentations – Exhibition Hall 3 & 4, Ground Floor | Industry Sponsored | Industry Sponsored | Industry Sponsored | ||||||
| 14:00-15:30 | Scientific (S18): Antimicrobials and Vaccines – Equitable Global Access |
Oral Abstract Presentations (O8) | Scientific (S19): Fungal resistance, diagnostics, and therapy updates |
Scientific (S20): New targets and approaches to vaccines |
Policy Session (p3): Policy Discussion – Advancing Clinical Trials |
Scientific (S21): Biomedical interventions on STI prevention |
Scientific (S22): Dengue |
|||
| 15:30-16:00 | Coffee Break (Exhibition Hall 3 & 4, Ground Floor) | |||||||||
| 16:00-17:00 | Scientific (S23): Current updates in tuberculosis |
Oral Abstract Presentations (O9) | Scientific (S24): What’s new in microbacteriology? |
Scientific (S25): GeoHealth |
Policy Session (p4): Policy Discussion – Sources of Funding |
Scientific (S26): Interacting with the online world: Misinformation & Vaccine Confidence |
||||
| 17:00-18:30 | Plenary 6: Emerging and re-emerging issues in STIs |
|||||||||
| Closing remarks: Paul Tambyah |
||||||||||